(Follica) hey, what ever happened to the focus on WNT signalling?

Lately all the patents & discussions seem focused entirely on the EGF-receptor blocking issue alone.

But the Follica talk used to be all about WNT signalling, kinds of Lithium, several times the density over natural regrowth with increased signalling up to the 45-day mark, etc.

Did Follica itself shift its focus?

Or am I just noticing a shift in what aspects of Follica’s deal that the MPB crowd is discussing?

I was wondering about the same thing.